Short-Term Efficacy of Using a Novel Low-Volume Bone Marrow Aspiration Technique to Treat Knee Osteoarthritis: A Retrospective Cohort Study.


Journal

Stem cells international
ISSN: 1687-966X
Titre abrégé: Stem Cells Int
Pays: United States
ID NLM: 101535822

Informations de publication

Date de publication:
2022
Historique:
received: 04 02 2022
revised: 19 10 2022
accepted: 21 10 2022
entrez: 28 11 2022
pubmed: 29 11 2022
medline: 29 11 2022
Statut: epublish

Résumé

Intra-articular bone marrow concentrate (BMC) and aspirate (BMA) injections have been used with mixed results to treat osteoarthritis (OA). Given the various aspiration and concentration methods available for preparing bone marrow, more data are needed to identify the optimal bone marrow harvesting techniques to treat OA. This retrospective cohort study examined the effect of using low-volume BMAs harvested using the Marrow Cellution™ (MC) device on 160 patients (262 knees) suffering from pain due to knee OA, KL grades 2-4, that did not respond to conservative treatment. Changes in visual analog scores (VAS) for overall daily activity were examined over a six-month time frame in these patients (63.5 ± 0.97 years of age; 48.1% male). In addition, changes in the Western Ontario and McMaster Universities Arthritis Index (WOMAC) and Patient Global Impression of Change (PGIC scores) were examined over the same time frame in a smaller subset of patients (95 patients including 172 knees). There was a statistically significant improvement in VAS scores for overall daily activity 6 months postprocedure in the study population, 7.29 ± 0.27 vs. 3.76 ± 0.34 ( Knee OA patients treated with MC BMA intra-articular injections exhibited significant reductions in VAS pain scores and significant improvements in WOMAC scores that exceeded the minimal clinically important difference thresholds. In addition, reductions in VAS pain scores and improvements in WOMAC scores correlated with higher PGIC scores.

Sections du résumé

Background UNASSIGNED
Intra-articular bone marrow concentrate (BMC) and aspirate (BMA) injections have been used with mixed results to treat osteoarthritis (OA). Given the various aspiration and concentration methods available for preparing bone marrow, more data are needed to identify the optimal bone marrow harvesting techniques to treat OA.
Methods UNASSIGNED
This retrospective cohort study examined the effect of using low-volume BMAs harvested using the Marrow Cellution™ (MC) device on 160 patients (262 knees) suffering from pain due to knee OA, KL grades 2-4, that did not respond to conservative treatment. Changes in visual analog scores (VAS) for overall daily activity were examined over a six-month time frame in these patients (63.5 ± 0.97 years of age; 48.1% male). In addition, changes in the Western Ontario and McMaster Universities Arthritis Index (WOMAC) and Patient Global Impression of Change (PGIC scores) were examined over the same time frame in a smaller subset of patients (95 patients including 172 knees).
Results UNASSIGNED
There was a statistically significant improvement in VAS scores for overall daily activity 6 months postprocedure in the study population, 7.29 ± 0.27 vs. 3.76 ± 0.34 (
Conclusions UNASSIGNED
Knee OA patients treated with MC BMA intra-articular injections exhibited significant reductions in VAS pain scores and significant improvements in WOMAC scores that exceeded the minimal clinically important difference thresholds. In addition, reductions in VAS pain scores and improvements in WOMAC scores correlated with higher PGIC scores.

Identifiants

pubmed: 36440184
doi: 10.1155/2022/5394441
pmc: PMC9682226
doi:

Types de publication

Journal Article

Langues

eng

Pagination

5394441

Informations de copyright

Copyright © 2022 Daniel Kuebler et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

J Arthroplasty. 2011 Aug;26(5):668-73
pubmed: 20875943
Bone Marrow Transplant. 1990 Aug;6(2):103-7
pubmed: 2207448
J Pain Res. 2018 Oct 05;11:2189-2196
pubmed: 30323653
Clin Sports Med. 2017 Jul;36(3):457-468
pubmed: 28577706
Int Orthop. 2021 Feb;45(2):391-399
pubmed: 32617651
Ann Rheum Dis. 2020 Jun;79(6):819-828
pubmed: 32398285
Cytotherapy. 2012 Sep;14(8):917-24
pubmed: 22687188
J Cell Physiol. 2007 Nov;213(2):341-7
pubmed: 17620285
J Transl Med. 2019 Jan 5;17(1):10
pubmed: 30611285
Osteoarthritis Cartilage. 2019 Oct;27(10):1403-1404
pubmed: 31153985
Clin Sports Med. 2019 Jan;38(1):123-141
pubmed: 30466718
Ann Rheum Dis. 2014 Jul;73(7):1323-30
pubmed: 24553908
Am J Sports Med. 2017 Jan;45(1):82-90
pubmed: 27566242
Br Med Bull. 2008;87:77-95
pubmed: 18676397
Arthrosc Sports Med Rehabil. 2021 Aug 14;3(5):e1431-e1440
pubmed: 34712981
PM R. 2021 Apr;13(4):387-396
pubmed: 32500620
Arthrosc Tech. 2020 Nov 20;9(11):e1773-e1777
pubmed: 33294339
J Orthop Sports Phys Ther. 2012 Aug;42(8):716-23
pubmed: 22402677
Clin Med Insights Arthritis Musculoskelet Disord. 2018 Jun 18;11:1179544118781080
pubmed: 29977117
Regen Med. 2016 Sep;11(6):511-20
pubmed: 27527808
J Arthroplasty. 2019 Apr;34(4):801-813
pubmed: 30612835
BMC Musculoskelet Disord. 2015 Sep 18;16:258
pubmed: 26385099
J Bone Joint Surg Am. 2005 Jul;87(7):1430-7
pubmed: 15995108
Crit Rev Phys Rehabil Med. 2012;24(3-4):251-264
pubmed: 25750483
Arthritis Rheum. 2001 Jun;44(6):1237-47
pubmed: 11407681
Biomed Res Int. 2014;2014:370621
pubmed: 25276781
Int Orthop. 2021 Feb;45(2):525-538
pubmed: 32661635
Clin Geriatr Med. 2010 Aug;26(3):355-69
pubmed: 20699159
Eur J Orthop Surg Traumatol. 2014 Dec;24(8):1505-11
pubmed: 24398701
Clin Sports Med. 2019 Jan;38(1):1-15
pubmed: 30466716
Arthroscopy. 2020 Mar;36(3):859-861
pubmed: 32139063
Int Orthop. 2014 Sep;38(9):1811-8
pubmed: 24913770
Stem Cell Res Ther. 2012 Jul 09;3(4):25
pubmed: 22776206
Stem Cells. 2015 Jan;33(1):146-56
pubmed: 25187512
Disabil Rehabil. 2022 Jun 11;:1-7
pubmed: 35695001
J Bone Joint Surg Am. 1997 Nov;79(11):1699-709
pubmed: 9384430
Orthopedics. 2016 Jan-Feb;39(1):55-62
pubmed: 26730683
JBJS Rev. 2019 Aug;7(8):e5
pubmed: 31415278
Pain Manag. 2018 Jul 1;8(4):271-275
pubmed: 29898646
Regen Med. 2020 Jul;15(7):1851-1859
pubmed: 32885730
Orthop J Sports Med. 2020 Feb 18;8(2):2325967119900958
pubmed: 32118081
Orthop J Sports Med. 2016 Jan 13;4(1):2325967115625481
pubmed: 26798765
Int Orthop. 2013 Nov;37(11):2279-87
pubmed: 23881064
Knee. 2020 Oct;27(5):1627-1634
pubmed: 33010782
Ann Rheum Dis. 2005 Jan;64(1):29-33
pubmed: 15208174
Acta Orthop. 2019 Jun;90(3):281-285
pubmed: 30739559
BMC Musculoskelet Disord. 2015 Oct 26;16:321
pubmed: 26503103
Stem Cells Int. 2019 Apr 7;2019:3826054
pubmed: 31089328

Auteurs

Daniel Kuebler (D)

Department of Biology, Franciscan University of Steubenville, Steubenville, OH 43952, USA.

Alexandra Schnee (A)

Atlas Medical Center, Irving TX 75062, USA.

Lisa Moore (L)

Atlas Medical Center, Irving TX 75062, USA.

Jason Kouri (J)

Atlas Medical Center, Irving TX 75062, USA.

Alexis McLaughlin (A)

Atlas Medical Center, Irving TX 75062, USA.

Robert Hanson (R)

Atlas Medical Center, Irving TX 75062, USA.

Patrick Kuebler (P)

Department of Biology, Franciscan University of Steubenville, Steubenville, OH 43952, USA.

Ignacio Dallo (I)

O.A.S.I. Bioresearch Foundation, Gobbi NPO, Milan, Italy.

Alberto Gobbi (A)

O.A.S.I. Bioresearch Foundation, Gobbi NPO, Milan, Italy.

Classifications MeSH